Indian drugmakers launch affordable generic versions of Ozempic & Wegovy, slashing costs by 70%. Increased access to...
medical devices
Indian drugmakers compete for obesity market share as generic weight-loss drugs drive prices down, increasing access but...
Alkem Labs enters India's weight-loss market with Semaglutide injection, offering a cost-effective solution for diabetes and weight...
Dr. Reddy's Laboratories introduces Obeda, a semaglutide injectable, in India, enhancing their diabetes care portfolio. A new...
Dr. Reddy's Laboratories introduces 'Obeda', a semaglutide version for diabetes management in India. Aims to expand its...
Dr. Reddy's introduces Obeda, a generic semaglutide injection, the first DCGI-approved treatment for Type 2 diabetes in...
Helium supply disruptions in West Asia threaten MRI services in India, driving up costs for healthcare providers...
Mave Health secures $2.1M seed funding led by Blume Ventures to launch innovative mental health wearable tech...
Agilent Technologies acquires Biocare Medical for $950M, a strategic move in the MedTech sector. This deal strengthens...
Cipla USA recalls Nilotinib anti-cancer capsules (150mg and 200mg) due to a manufacturing defect, as confirmed by...